![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Healthcare Loc | LSE:HLO | London | Ordinary Share | GB00B0MD8242 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.75 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMHLO
RNS Number : 6729W
Healthcare Locums PLC
02 February 2012
Healthcare Locums plc
("HCL" or the "Company")
Directorate Change
Appointment of Chief Finance Officer (Designate)
The Board of Healthcare Locums plc, a leading provider of staffing solutions in the health and social care sectors, is pleased to announce the appointment of Sue Bygrave, 46, as Chief Finance Officer (Designate), succeeding Bill Jessup, Interim Chief Finance Officer who will step down on publication of the financial accounts for the year ended 31 December 2011. Sue will formally take up her role as an Executive Director on the Board of HCL on 6 February 2012 and will assume responsibility for all accounting activity across the Group including operations in Australia.
Sue joins from Biome Technologies plc, the AIM listed bioplastics and RF (radio frequency) technology business, where she was Group Finance Director supporting an acquisition strategy whilst driving organic growth. Prior to Biome Technologies, Sue was Group Finance Director of VEGA Group plc, an organisation delivering consulting, technology and managed solutions into Aerospace, Defence and Government Markets. She was Joint Chair of the Executive Management Team that saw the repositioning of the business as an independent specialist services company prior to its acquisition by Finmeccanica in 2008.
Sue is an ACA qualified accountant and began her career with KPMG in Audit.
Peter Sullivan, Chairman of HCL, commented: "We are delighted that Sue is joining the company as Chief Finance Officer. She brings with her a wealth of experience which will be invaluable to the business as we continue to transform the organisation. We look forward to welcoming her to the Board."
Sue holds or has held directorships in the five years preceding her appointment at HCL as follows:
Current directorships and Past directorships and partnerships partnerships -------------------------- -------------------------------------------- None Biome Technologies plc (Jan 2009-Oct 2011) -------------------------- -------------------------------------------- Mettoni Group plc (placed into receivership in April 2009) -------------------------- -------------------------------------------- VEGA Group plc (Nov 2004-Feb 2008) -------------------------- --------------------------------------------
There are no further disclosures to be made with regards to this appointment under paragraph (g) of Schedule 2 of the AIM Rules.
Ends
For further information please contact:
Healthcare Locums plc
Stephen Burke, Chief Executive Officer
020 7451 1451
Investec Bank plc
Gary Clarence/Patrick Robb/Daniel Adams
020 7597 5970
Pelham Bell Pottinger
David Rydell/Emma Kent/Duncan Mayall/Charlotte Offredi
020 7861 3233
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOAKLLBBLLFLBBX
1 Year Healthcare Locums Chart |
1 Month Healthcare Locums Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions